Women's Health

A new treatment for postpartum depression has been developed with rapid onset, cutting down the time it has taken previous treatments to take effect by weeks or months.

Compared with women who aren’t experiencing menopausal symptoms, women in the perimenopause stage were approximately 40% more likely to experience depressive symptoms.

Venture capital investments in women's health are growing, with innovation looking beyond traditional avenues.

Tisotumab vedotin-tftv is the first antibody-drug conjugate to demonstrate positive overall survival data in patients with previously treated recurrent or metastatic cancer.

Pivmecillinam (Pivya; UTILITY therapeutics Ltd) tablets were approved for female adults with uncomplicated urinary tract infection caused by Escherichia coli, Proteus mirabilis, and Staphylococcus saprophyticus.

Access to birth control is a crucial part of preventive health care, but financial barriers persist

Opill is a nonprescription, progestin-only contraceptive pill, with nearly 50 years of use and data supporting the safety and effectiveness of progestin-only pills.

In the RUBY phase 3 trial, dostarlimab (Jemperli; GSK) with niraparib (Zejula; GSK) had significant progression free survival compared to the standard of care.

Fortification with folic acid may be especially beneficial in countries that do not have mandated folic acid fortification regulations.

The treatment is indicated for patients with FRα-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancers.

Oteseconazole (Vivjoa; Mycovia Pharmaceutical Inc) is the first and only medication for this indication in postmenopausal women and those who do not have reproductive potential.

The early phase clinical trial, which ended prematurely in 2013 due to funding challenges, further illustrates disparities in health equity in clinical research.

The designation is for all patients with low-grade serous ovarian cancer, regardless of their KRAS status and after 1 or more prior lines of therapy.

There have been ongoing concerns about the long-term effects of prenatal exposure on neurodevelopment.

Omega-3s are important during pregnancy because they can reduce risk of preeclampsia and other negative health outcomes.

Investigators at Duke University and the University of North Carolina determine what causes recurrent UTIs, even after antibiotics cleared the bacterial infection.

Walgreens will start dispensing the abortion pill as soon as a week.

Dietary interventions can reduce the risk of preeclampsia and other hypertensive conditions that occur during pregnancy.

In LePage v. Center for Reproductive Medicine, the Alabama Supreme Court ruled that “extrauterine embryos” are considered children, causing some infertility clinics to halt IVF processes.

In a study, nipocalimab helped more than 50% of patients with high-risk of hemolytic disease of the fetus and newborn achieve a safe live birth.

Providing continuity of care with the involvement of midwives also appeared to reduce inequities in care for multi-ethnic patients.

However, different recommendations may actually be valuable, as different countries have different population-based needs.

Supplementation during pregnancy also reduced communication warning behaviors in children who developed autism compared to the children of women who did not take supplements.

Recommendations range from contraceptives to heat therapy to holistic use of spices.

These patients may have a similar genetic susceptibility for type 2 diabetes.

Creating additional space for nursing mothers can be challenging in small pharmacies

Patients should work with clinicians to discuss controlled ovarian stimulation because there is still limited research.

The ampule of digoxin was accidentally taken from automated dispensing cabinet instead of bupivacaine

The results also indicated that stress and blood sugar levels were higher among women who had a college degree and women with a higher income.

The findings show a greater association with less ideal cardiovascular health scores for those who experienced their first infertility before age 35.